Net profit of Beryl Drugs declined 96.30% to Rs 0.01 crore in the quarter ended September 2024 as against Rs 0.27 crore during the previous quarter ended September 2023. Sales declined 30.14% to Rs 5.61 crore in the quarter ended September 2024 as against Rs 8.03 crore during the previous quarter ended September 2023.
| Particulars | Quarter Ended |
| Sep. 2024 | Sep. 2023 | % Var. |
| Sales | 5.61 | 8.03 | -30 |
| OPM % | 9.98 | 8.97 | - |
| PBDT | 0.44 | 0.62 | -29 |
| PBT | 0.11 | 0.33 | -67 |
| NP | 0.01 | 0.27 | -96 |